BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PYVOBJECT//NONSGML Version 1//EN
BEGIN:VTIMEZONE
TZID:Europe/Brussels
BEGIN:STANDARD
DTSTART:20001029T030000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=10
TZNAME:CET
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
END:STANDARD
BEGIN:DAYLIGHT
DTSTART:20000326T020000
RRULE:FREQ=YEARLY;BYDAY=-1SU;BYMONTH=3
TZNAME:CEST
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
UID:20261117T001641Z - 93269@5b037afdca81
DTSTART;TZID=Europe/Brussels:20261210T160000
DTEND;TZID=Europe/Brussels:20261210T173000
CREATED:20261117T001641Z
DESCRIPTION:<a href="https://community-scdm.org/event/scdm-webinar-the-2026
 -clinical-data-science-survey-aligning-data-strategy-actionable-ai-and-ope
 rational-reality-30/register">SCDM Webinar | The 2026 Clinical Data Scienc
 e Survey: Aligning Data Strategy\, Actionable AI\, and Operational Reality
  </a>\nSCDM Webinar The 2026 Clinical Data Science Survey: Aligning Data S
 trategy\, Actionable AI\, and Operational Reality Description: The shift f
 rom traditional data management to Clinical Data Science is a top priority
  for many clinical development organizations\, driven by ICH E6(R3) mandat
 es\, the proliferation of data sources\, and the explosion of AI. But how 
 does this evolution fit into the daily realities of clinical teams? Join M
 edidata for the premiere of results from an industry survey on the current
  state of the transformation of clinical data management into Clinical Dat
 a Science. Our panel will share fresh industry data to assess real-world p
 rogress. We’ll examine common bottlenecks in trial execution—from stud
 y setup to data integration to data quality management—and provide actio
 nable advice on implementing automation and AI without compromising trust 
 or compliance. Key takeaways:Compare your processes against industry data 
 See how your data operations compare to fresh benchmarking data from Ident
 ify study build bottlenecksReview common causes of delay in EDC setup and 
 protocol amendments\, and explore Examine multi-source data realitiesLook 
 at real-world data on how teams manage non-EDC data (like eCOA\, labs\, an
 d assess progress in risk-based oversightEvaluate industry adoption of ris
 k-based approaches (RBDM/RB-CDM\, and RBQM) Understand AI trust boundaries
 Evaluate where your peers are comfortable using AI today\, what obstacles 
 Andy Gurd Senior Director\, Product Marketing Medidata\, Dassault Système
 s Andy Gurd is a Senior Director of Product Marketing at Medidata\, where 
 he leads the team responsible for product marketing for the Medidata Data 
 Experience. Andy has over 25 years of technology product marketing experie
 nce\, the last 12 of which have been in clinical research technologies and
  services\, including 6 years at Parexel. Before entering the life [...]
DTSTAMP:20261117T001641Z
SUMMARY:SCDM Webinar | The 2026 Clinical Data Science Survey: Aligning Data
  Strategy\, Actionable AI\, and Operational Reality 
X-ALT-DESC;FMTTYPE=text/html:<a href="https://community-scdm.org/event/scdm
 -webinar-the-2026-clinical-data-science-survey-aligning-data-strategy-acti
 onable-ai-and-operational-reality-30/register">SCDM Webinar | The 2026 Cli
 nical Data Science Survey: Aligning Data Strategy\, Actionable AI\, and Op
 erational Reality </a>\nSCDM Webinar The 2026 Clinical Data Science Survey
 : Aligning Data Strategy\, Actionable AI\, and Operational Reality Descrip
 tion: The shift from traditional data management to Clinical Data Science 
 is a top priority for many clinical development organizations\, driven by 
 ICH E6(R3) mandates\, the proliferation of data sources\, and the explosio
 n of AI. But how does this evolution fit into the daily realities of clini
 cal teams? Join Medidata for the premiere of results from an industry surv
 ey on the current state of the transformation of clinical data management 
 into Clinical Data Science. Our panel will share fresh industry data to as
 sess real-world progress. We’ll examine common bottlenecks in trial exec
 ution—from study setup to data integration to data quality management—
 and provide actionable advice on implementing automation and AI without co
 mpromising trust or compliance. Key takeaways:Compare your processes again
 st industry data See how your data operations compare to fresh benchmarkin
 g data from Identify study build bottlenecksReview common causes of delay 
 in EDC setup and protocol amendments\, and explore Examine multi-source da
 ta realitiesLook at real-world data on how teams manage non-EDC data (like
  eCOA\, labs\, and assess progress in risk-based oversightEvaluate industr
 y adoption of risk-based approaches (RBDM/RB-CDM\, and RBQM) Understand AI
  trust boundariesEvaluate where your peers are comfortable using AI today\
 , what obstacles Andy Gurd Senior Director\, Product Marketing Medidata\, 
 Dassault Systèmes Andy Gurd is a Senior Director of Product Marketing at 
 Medidata\, where he leads the team responsible for product marketing for t
 he Medidata Data Experience. Andy has over 25 years of technology product 
 marketing experience\, the last 12 of which have been in clinical research
  technologies and services\, including 6 years at Parexel. Before entering
  the life [...]
END:VEVENT
END:VCALENDAR
